Vice President / IAVI
International AIDS Vaccine Initiative 125 Broad Street, 9th Floor New York, NY 10004
Sangeetha Sagar has 29 years of experience in all aspects of CMC development and supply of vaccines, gene and cell therapy products, and mono and multispecific antibodies and conjugates. She previously worked for various large biopharma companies, leading end-to-end development of vaccines and biotherapeutics for Ebola, Covid, HPV and more. Her goal is to play a pivotal role in developing vaccines and medicine that prevent and treat global infectious diseases and reach those in greatest need.